dexmedetomidine has been researched along with Airflow Obstruction, Chronic in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, XH; Li, L; Li, SS; Shen, W; Sun, SB; Weng, ZY; Xiong, GS; Yang, GM; Ye, XL | 1 |
| Li, N; Li, Q; Li, S; Li, T; Wu, D; Wu, Y; Xing, D; Xiong, L | 1 |
| Dong, N; Qian, H; Yu, W; Zhang, J | 1 |
| Hattori, K; Kido, H; Komasawa, N; Minami, T; Omori, M | 1 |
| Ban, MG; Kim, N; Lee, CY; Lee, SH; Oh, YJ | 1 |
| Li, N; Lin, CS; Liu, J; Liu, L; Ouyang, BS; Xing, DD | 1 |
| Cata, JP; Folch, E | 1 |
| Iizuka, T; Notoya, A; Shimoyama, N | 1 |
| Kitamura, H; Kitayama, M; Komatsu, H; Tanimo, T; Yamaki, R | 1 |
| Rich, JM | 1 |
2 trial(s) available for dexmedetomidine and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
[Dexmedetomidine improves function of lung oxygenation in patients with moderate chronic obstructive pulmonary disease underwent lung cancer surgery].
Topics: Adrenergic alpha-2 Receptor Agonists; Dexmedetomidine; Humans; Lung; Lung Neoplasms; Maintenance Chemotherapy; Oxygen Consumption; Pulmonary Disease, Chronic Obstructive; Pulmonary Ventilation; Respiratory Mechanics | 2017 |
Effects of dexmedetomidine on oxygenation and lung mechanics in patients with moderate chronic obstructive pulmonary disease undergoing lung cancer surgery: A randomised double-blinded trial.
Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Bronchodilator Agents; Dexmedetomidine; Double-Blind Method; Drug Administration Schedule; Female; Hospitals, University; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Pulmonary Disease, Chronic Obstructive; Republic of Korea; Respiratory Mechanics; Severity of Illness Index; Thoracic Surgery, Video-Assisted; Time Factors; Treatment Outcome | 2016 |
8 other study(ies) available for dexmedetomidine and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Therapeutic efficacy of dexmedetomidine on chronic obstructive pulmonary disease via downregulating lncRNA PACER.
Topics: Animals; Cell Movement; Cell Proliferation; Dexmedetomidine; Down-Regulation; Epithelial Cells; Humans; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; RNA, Long Noncoding | 2020 |
Dexmedetomidine targets miR-146a and participates in the progress of chronic obstructive pulmonary disease in vivo and in vitro.
Topics: Animals; Apoptosis; Cell Line; Cell Proliferation; Cells, Cultured; Dexmedetomidine; Humans; Interleukin-1beta; Interleukin-6; MicroRNAs; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; Respiratory Mucosa; Tumor Necrosis Factor-alpha | 2021 |
[Ultrasound-guided Thoracic Epidural and Spinal Anesthesia for the Management of Patients Undergoing Systemic Neurofibroma Resection].
Topics: Adult; Anesthesia, Epidural; Anesthesia, Spinal; Bupivacaine; Dexmedetomidine; Humans; Male; Neurofibroma; Pain, Postoperative; Pulmonary Disease, Chronic Obstructive; Ropivacaine; Skin Neoplasms; Ultrasonography | 2016 |
Dexmedetomidine protected COPD-induced lung injury by regulating miRNA-146a.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Apoptosis; Dexmedetomidine; Disease Models, Animal; Gene Expression Regulation; Interleukin-1beta; Lung; MicroRNAs; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; Respiratory Function Tests; Tumor Necrosis Factor-alpha | 2016 |
Dexmedetomidine as sole sedative during percutaneous carotid artery stenting in a patient with severe chronic obstructive pulmonary disease.
Topics: Aged; Carotid Stenosis; Dexmedetomidine; Female; Humans; Hypnotics and Sedatives; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Stents | 2009 |
[Dexmedetomidine for endoscopic submucosal dissection in a patient with severe chronic obstructive pulmonary disease].
Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Analgesics; Anesthesia, General; Dexmedetomidine; Gastric Mucosa; Gastroscopy; Humans; Hypnotics and Sedatives; Male; Monitoring, Intraoperative; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Stomach Neoplasms | 2011 |
[Successful anesthetic management in a patient with chronic obstructive pulmonary disease (COPD) using dexmedetomidine and combined spinal-epidural anesthesia for low anterior resection of the rectum].
Topics: Aged; Anesthesia, Epidural; Anesthesia, Spinal; Conscious Sedation; Dexmedetomidine; Humans; Male; Perioperative Care; Pulmonary Disease, Chronic Obstructive; Rectal Neoplasms; Rectum; Severity of Illness Index | 2012 |
Dexmedetomidine as a sole sedating agent with local anesthesia in a high-risk patient for axillofemoral bypass graft: a case report.
Topics: Aged; Anesthetics, Local; Conscious Sedation; Dexmedetomidine; Heart Failure; Humans; Hypnotics and Sedatives; Male; Peripheral Vascular Diseases; Pulmonary Disease, Chronic Obstructive | 2005 |